What is the main topic?

The main topic is Novartis closing Morphosys, affecting 330 jobs as part of its integration strategy.

Why is Novartis closing Morphosys?

Novartis is closing Morphosys to integrate its portfolio activities into Novartis, consolidating operations.

How many jobs are affected by the closure?

The closure of Morphosys by Novartis will affect 330 jobs.

Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Finance > Some 330 jobs hit as Novartis closes Morphosys, WiWo reports

Finance

Some 330 jobs hit as Novartis closes Morphosys, WiWo reports

Published by Global Banking & Finance Review®

Posted on December 19, 2024

1 min read

Last updated: January 27, 2026

Novartis announces job cuts as it closes Morphosys, impacting 330 employees - Global Banking & Finance Review — Image illustrating the recent closure of Morphosys by Novartis, resulting in the loss of 330 jobs. This significant development in the biotech sector highlights the ongoing changes in the finance and pharmaceutical industries.

Some 330 jobs hit as Novartis closes Morphosys, WiWo reports

Quick Summary

Novartis to Shut Down Morphosys, Impacting 330 Jobs

Key Takeaways

Frequently Asked Questions about Some 330 jobs hit as Novartis closes Morphosys, WiWo reports